SCLC: Treatment Advancing One Small, but Quickening, Step at a Time

November 3, 2021

Cancer Treatment Centers of America® (CTCA) Atlanta hematologist and medical oncologist Dr. Herbert Duvivier authored an article published by Targeted Oncology on treatment options in the small cell lung cancer setting for Lung Cancer Awareness Month.

“There is hope for SCLC; we should not forget that NSCLC started in the same fashion and treatment was stagnant until the 2010s with the development of PD-1 and PD-L1 inhibitors. SCLC is at the beginning of its road of discovery and clinical trials and human endeavor will push development along.”

Read more here

About Cancer Treatment Centers of America
Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.